Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Prometic Life Sciences
Prometic Life Sciences
Activities:
Manufacturing
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Optimising RNA production for faster and cheaper pharmaceutical manufacturing
RNA production can be a lengthy and complex process, but the Ntensify platform could change this by diminishing development times, decreasing production costs and allowing the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Owlstone Medical bags $6.5m to optimise infectious disease diagnostic tool
The Bill & Melinda Gates Foundation has funded the bolstering of the Breath Biopsy platform, as well as research into breath biomarkers in tuberculosis (TB) and HIV
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Design & Build
Keyplants awarded US$1m contract by Russian biotech giant Generium
KeyPlants has been awarded a conceptual design contract for the MasterPlasma fractionation facility in the Vladimir Region of Russia
Manufacturing
ProMetic signs 15-year manufacturing contract with Emergent BioSolutions
Emergent facility in Winnipeg will manufacture plasma-derived biopharmaceuticals using the ProMetic Plasma Protein Purification System (PPPS)
Research & Development
ProMetic appoints new Chief Medical Officer
Dr John Moran will take up the role on 1 March
Research & Development
ProMetic enters CAD$1.6m development deal with leading vaccines company
For the supply of an affinity resin for use in scale-up and commercial production
Manufacturing
ProMetic and Sartorius Stedim Biotech expand collaboration
To promote turnkey solution for plasma-derived therapeutics
Research & Development
ProMetic Life Sciences and NantPharma to develop plasma-derived biopharmaceuticals
NantPharma pays initial US$2.5m to ProMetic
Manufacturing
ProMetic signs agreement to improve biopharmaceutical manufacturing process
Will receive initial service revenues of CAD800,000 during 2011
Subscribe now